Literature DB >> 13379520

Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin.

M FINLAND, W F JONES, R L NICHOLS.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/effects; CARBOMYCIN/effects; ERYTHROMYCIN/effects; MICROCOCCUS PYOGENES/effect of drugs on

Mesh：

Substances：

Year:  1956        PMID： 13379520     DOI： 10.3181/00379727-93-22766

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  12 in total

Review 1.  Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.

Authors:  C Cocito
Journal:  Microbiol Rev       Date:  1979-06

2.  ANTIBACTERIAL ACTIVITY OF LINCOMYCIN AND PRISTINAMYCIN: A COMPARISON WITH ERYTHROMYCIN.

Authors:  M BARBER; P M WATERWORTH
Journal:  Br Med J       Date:  1964-09-05

3.  The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin.

Authors:  E J LOWBURY; L HURST
Journal:  J Clin Pathol       Date:  1959-03       Impact factor: 3.411

4.  [Sensitivity of some nonsporous anaerobes to new antibiotics in vitro. II. Oleandomycin].

Authors:  U BERGER
Journal:  Z Hyg Infektionskr       Date:  1958

5.  [Sensitivity of some nonsporous anaerobes to spiramycin in vitro].

Authors:  U BERGER
Journal:  Z Hyg Infektionskr       Date:  1958

6.  The erythromycin group of antibiotics.

Authors:  L P GARROD
Journal:  Br Med J       Date:  1957-07-13

Review 7.  Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification.

Authors:  R Leclercq; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

8.  In vitro development of resistance to erythromycin, other macrolide antibiotics, and lincomycin in Mycoplasma pneumoniae.

Authors:  Y Nitu; S Hasegawa; H Kubota
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

9.  In vitro induction of resistance to erythromycin by its metabolite.

Authors:  J Majer
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

10.  Characterization of erythromycin-resistant isolates of Staphylococcus aureus recovered in the United States from 1958 through 1969.

Authors:  F G Nicola; L K McDougal; J W Biddle; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.